Recombinant Mouse Myostatin

Using Recombinant Mouse Myostatin in research is essential for studying the regulation of skeletal muscle growth, muscle-wasting diseases, and metabolic or developmental processes in murine models. Myostatin (GDF-8) is a well-characterized negative regulator of muscle mass, and recombinant forms allow for precise, controlled experimentation in vitro and in vivo.

Key scientific applications and rationale include:

• Modeling Muscle Growth and Atrophy: Recombinant mouse myostatin is used to investigate the molecular mechanisms underlying muscle hypertrophy and atrophy, as it inhibits muscle cell proliferation and differentiation. This is critical for understanding conditions such as muscular dystrophy, cachexia, and sarcopenia.

• Therapeutic Target Validation: By administering recombinant myostatin or its inhibitors, researchers can evaluate potential therapies for muscle-wasting disorders. For example, inhibition of myostatin in mouse models increases muscle mass and function, supporting its therapeutic relevance.

• Bone and Muscle Regeneration Studies: Recombinant myostatin and its inhibitors have been shown to influence both muscle and bone repair. In mouse injury models, blocking myostatin with recombinant propeptides enhances muscle regeneration and bone healing, making it valuable for musculoskeletal research.

• Metabolic and Developmental Research: Myostatin also regulates energy homeostasis and metabolic pathways in muscle and other tissues. Recombinant protein enables detailed studies of these processes in controlled settings.

• Bioassays and Cell Culture: Recombinant mouse myostatin is widely used in bioassays to assess its biological activity, such as inhibition of myoblast differentiation or induction of specific gene expression in cell lines.

• Comparative and Mechanistic Studies: Using recombinant mouse myostatin allows for direct comparison with human or rat orthologs, facilitating cross-species analysis of myostatin function and signaling.

In summary, recombinant mouse myostatin is a critical reagent for dissecting the molecular, cellular, and physiological roles of myostatin in muscle and bone biology, disease modeling, and therapeutic development.

Yes, recombinant mouse myostatin can be used as a standard for quantification or calibration in ELISA assays, provided that the recombinant protein is compatible with the detection antibodies and assay format of your specific ELISA kit.

Several sources confirm this practice:

• Recombinant GDF-8/Myostatin (including mouse) is commonly used as a calibration standard in ELISA kits designed to measure myostatin levels. For example, the R&D Systems Quantikine ELISA kit is calibrated against a highly purified NS0-expressed recombinant mature GDF-8 (mouse), and the kit's standard curve is generated using this recombinant protein. This indicates that recombinant myostatin is suitable for generating standard curves to quantify endogenous myostatin in samples.

• Other ELISA kits (such as those from RayBiotech, MyBioSource, and Novus Biologicals) also include recombinant myostatin as part of their standard curve for quantification.

However, there are a few important considerations:

1. Compatibility: Ensure that the recombinant myostatin you are using is recognized by the capture and detection antibodies in your ELISA kit. Some kits are designed to detect only native myostatin or may have different affinities for recombinant versus native forms.

2. Formulation: If the recombinant myostatin is supplied with a carrier protein (such as BSA), this may interfere with certain ELISA formats. For most ELISA applications, a carrier-free (CF) version is preferred to avoid potential interference.

3. Activity and Purity: The recombinant protein should be of high purity and, if possible, validated for biological activity to ensure accurate quantification.

In summary, recombinant mouse myostatin is appropriate for use as a standard in ELISA assays, especially when the kit is designed to detect recombinant myostatin or when the recombinant protein is compatible with the assay's detection system. Always check the manufacturer's recommendations for your specific ELISA kit.

Recombinant Mouse Myostatin has been validated for several applications in published research, primarily focusing on its biological activity and functional effects in both in vitro and in vivo models. Key applications include:

• Functional Assay: Recombinant Mouse Myostatin is validated for use in functional assays to study its biological activity, such as its ability to regulate muscle cell proliferation and differentiation.
• Bioassay: It has been used in bioassays to assess its effects on muscle and bone repair, including studies on muscle regeneration and bone healing following injury.
• Cell Culture: The protein is applied in cell culture experiments to investigate its impact on muscle cells, including inhibition of muscle cell proliferation and modulation of muscle mass.
• In Vivo Studies: Recombinant Mouse Myostatin has been utilized in animal models to evaluate its role in muscle and bone repair, as well as its effects on muscle mass and strength in conditions such as muscular dystrophy.
• Surface Plasmon Resonance: It has been used in surface plasmon resonance assays to study interactions with other proteins and ligands, providing insights into its regulatory mechanisms.

These applications highlight the versatility of Recombinant Mouse Myostatin in both basic research and therapeutic development contexts.

To reconstitute and prepare Recombinant Mouse Myostatin protein for cell culture experiments, dissolve the lyophilized protein at 100 μg/mL in sterile 4 mM HCl, ideally containing at least 0.1% carrier protein such as bovine serum albumin (BSA) or human serum albumin (HSA) to stabilize the protein and prevent adsorption to surfaces.

Step-by-step protocol:

• Warm the vial to room temperature before opening to avoid condensation.
• Centrifuge the vial briefly to collect the powder at the bottom.
• Add sterile 4 mM HCl to achieve a final concentration of 100 μg/mL. For example, add 100 μL of 4 mM HCl to 10 μg of protein.
• Include 0.1% BSA or HSA in the reconstitution buffer if long-term storage or repeated freeze-thaw is anticipated.
• Gently mix by pipetting up and down or by gentle vortexing. Avoid vigorous agitation.
• Aliquot the solution to minimize freeze-thaw cycles.
• Store reconstituted protein at 2–8 °C for up to 1 month, or at –20 °C to –70 °C for up to 3 months. Avoid repeated freeze-thaw cycles.

Dilution for cell culture:

• For cell-based assays, further dilute the stock solution into cell culture medium or phosphate-buffered saline (PBS) containing 0.1% BSA/HSA to the desired working concentration (e.g., 2–100 ng/mL, depending on your assay).

Additional notes:

• If your protocol or supplier recommends a different buffer (e.g., sterile water or 20 mM HCl), follow those instructions, but always check for protein solubility and stability.
• Always use sterile technique to prevent contamination.
• Confirm biological activity with a pilot experiment if possible.

This protocol ensures optimal solubility, stability, and activity of recombinant mouse myostatin for cell culture applications.